Analysis of Cryomass Technologies Inc. (CRYM)
Cryomass Technologies Inc. (CRYM) has shown some interesting price movements in the past few days.
- The price has been fluctuating between 0.039 and 0.075, with the most recent closing price at 0.05420.
- The Relative Strength Index (RSI) has been hovering around 50-70, indicating a moderate level of buying and selling pressure.
- The Moving Average Convergence Divergence (MACD) indicator has been positive, suggesting a bullish momentum.
- The Moving Averages (SMA, EMA, WMA) have been relatively close to each other, indicating a stable trend.
Overall, CRYM seems to be in a consolidation phase with some bullish signals. Traders and investors may want to monitor the price movements closely for potential trading opportunities.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate each year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There is a significant amount of debt in the company's capital structure, both short-term and long-term.
8. Retained earnings have been negative in some years, indicating losses or dividend payouts exceeding profits.
9. The company has been investing heavily in investments and advances as part of its non-current assets.
10. Overall, the company's financial position seems stable, but it should focus on managing its debt levels and improving profitability.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results for January 31, 2025, were released after hours. The results for October 31, 2024, were not supplied at the time. The results for August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive profit margin and healthy return on assets and equity. The balance sheet shows a decent current ratio, but a relatively high total debt to equity ratio. The income statement indicates significant revenue and EBITDA, with a good gross profit margin and earnings per share.
Moving on to stock statistics, the company has a low short ratio and short percent of shares outstanding, with a significant percentage held by institutions. The stock price summary shows a beta above 1, with the stock trading within a range of fifty-two-week low and high prices.
Valuation metrics reveal a relatively high PEG ratio and price to book ratio, with the stock trading at a forward and trailing PE ratio. The enterprise value, market capitalization, and other ratios provide insights into the company's valuation.
Lastly, dividends and splits information includes details on dividend rates, yields, payout ratio, and historical split dates. The company pays dividends with a forward annual dividend yield and has a 5-year average dividend yield.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- There was a decrease in sales from 2022 to 2023.
- Sales have generally been increasing over the past four years, with a significant jump from 2020 to 2021.
- The company experienced its highest sales figure in 2022.
These trends can provide insights into the company's performance and growth trajectory over the specified period.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance/payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities show a mix of stability in operations and variability in financing and investing decisions.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago. The range of estimates is between $1.27 and $1.36, with 26 analysts providing forecasts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, lower than the $1.46 reported a year ago. The EPS estimates range from $1.44 to $1.63, with 25 analysts contributing to the estimates.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, up from $6.13 in the previous year. The EPS estimates for the full year range from $6.43 to $6.92, with 39 analysts providing forecasts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 in the previous year. The EPS estimates for the upcoming year range from $6.40 to $7.90, with 39 analysts contributing to the estimates.
Overall, the analysts are generally forecasting an increase in earnings per share for both the upcoming quarters and the full fiscal years, indicating positive growth expectations for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:
- The company is expected to experience a growth rate of 7.5% in the current year.
- The growth rate is projected to increase to 5.6% in the current quarter and further to 4.8% in the next quarter.
- Over the next year, the growth rate is expected to reach 9.7%.
- Looking ahead, the company is forecasted to achieve an annual growth rate of 11% over the next 5 years.
- However, when comparing to the past 5 years, where the company had an annual growth rate of 20.15%, the future growth rate is expected to be lower.
In summary, the company is expected to see steady growth in the near term, with a slightly higher growth rate in the next year and over the next 5 years compared to the current period.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price of the security is $191.57, which is below the median and average forecast, indicating that some analysts may expect the price to increase in the future.MACD of CRYM